MetaCap

DocGo (DCGO) vs LifeMD (LFMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

LifeMD (LFMD) has outperformed DocGo (DCGO) over the past year, losing 62.5% versus a loss of 81.9%. Over five years, LFMD leads with a -65.9% price change compared with -97.7% for DCGO. LifeMD is the larger company by market cap ($69.8 million vs $17.3 million), about 4.0 times the size.

On valuation, LifeMD trades at a lower forward P/E (9.3x vs 34.7x for DocGo). LifeMD converts more of its revenue into profit, with a net margin of 7.4% versus -56.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DCGO-81.92%LFMD-62.47%
+43%-23%-88%
Nov 21, 20251 yearNov 20, 2026
DCGO-98.16%LFMD-68.17%
+241%+63%-114%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DCGO versus LFMD key metrics
MetricDCGOLFMD
Share price$0.175$1.45
Market cap$17.32M$69.84M
1-day change+1.98%-9.40%
YTD return-80.07%-57.62%
1-year return-81.92%-62.47%
5-year return-97.71%-65.92%
Forward P/E34.759.32
EPS (TTM)$-1.83$-0.52
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$322.20M$194.06M
Revenue growth (YoY)-47.74%+25.34%
Net income (latest FY)$-182.40M$14.35M
Gross margin—85.72%
Operating margin-55.26%-3.95%
Net margin-56.61%7.40%
52-week high$1.10$5.38
52-week low$0.167$1.38
Distance from 52-week high-84.09%-73.14%
Analyst consensusbuystrong_buy
Avg. price target upside+974.29%+462.63%
Average volume729.51K929.40K
Shares outstanding98.99M48.33M
Employees2,537347
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • LifeMD is about 4.0 times larger than DocGo by market value ($69.84M vs $17.32M).
  • LFMD has outperformed DCGO by 19.5 percentage points over the past year.
  • LifeMD is more profitable, keeping 7.4 cents of every revenue dollar as net income versus -56.6 cents for DocGo.
  • LifeMD grew revenue faster in its latest fiscal year (+25.34% vs -47.74%).

About DocGo

DCGO stock →

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom.

Health Care · Medical/Nursing Services · 2,537 employees

About LifeMD

LFMD stock →

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.

Health Care · Medical/Nursing Services · 347 employees

DCGO vs LFMD FAQ

Which is bigger, DocGo or LifeMD?

LifeMD (LFMD) is larger, with a market capitalization of $69.84M compared with $17.32M for DocGo (DCGO).

Which stock has performed better over the past year, DCGO or LFMD?

LFMD returned -62.47% over the past 12 months, compared with -81.92% for DCGO (price return, excluding dividends). Past performance does not predict future results.

Are DocGo and LifeMD in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons